FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912691364> ?p ?o ?g. }

• W2912691364 endingPage "364" @default.
• W2912691364 startingPage "355" @default.
• W2912691364 abstract "Management of metastatic genitourinary malignancies has recently been transformed through the use of immune checkpoint inhibitors. The best way to integrate them into local treatment paradigms is still under investigation. To systematically evaluate evidence regarding the use of immunotherapy in the treatment of local disease, in both the perioperative and the metastatic setting. We performed a critical review of PubMed and ClinicalTrials.gov according to the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) statement. Prospective and retrospective studies between 2011 and 2018 were included. Twenty-four publications were selected for inclusion, including 10 on urothelial carcinoma, seven on renal cell carcinoma, six on prostate cancer, and one on germ-cell cancer. Prospective early-phase trials investigating neoadjuvant immunotherapy prior to cystectomy in urothelial carcinoma suggest a high rate of pathological complete response, from 29% with atezolizumab to 39.5% with pembrolizumab. Several neoadjuvant and adjuvant trials are still ongoing in bladder, renal, and prostate cancers, before or after surgery. The combination of immunotherapy and radiotherapy is being explored and could offer an interesting strategy for definitive treatment modality with curative intent. Finally, in metastatic disease, delayed local treatment could be discussed after immunotherapy in selected patients with an excellent radiographic response. Little evidence exists on the oncological impact of immunotherapy on the local treatment of genitourinary malignancies, but preliminary results are encouraging and many prospective trials are ongoing. In this study, we review recent advances in immunotherapy and its role in local treatment. Immunotherapy is evaluated before or after surgery, or in combination with radiotherapy for localized disease. Ongoing trials will bring clarity on the local downstaging effect of immunotherapy and its association with oncological and functional outcomes." @default.
• W2912691364 created "2019-02-21" @default.
• W2912691364 creator A5027991868 @default.
• W2912691364 creator A5032422193 @default.
• W2912691364 creator A5034005227 @default.
• W2912691364 creator A5069476166 @default.
• W2912691364 creator A5074336646 @default.
• W2912691364 date "2019-07-01" @default.
• W2912691364 modified "2023-09-23" @default.
• W2912691364 title "Effect of Immunotherapy on Local Treatment of Genitourinary Malignancies" @default.
• W2912691364 cites W1966280949 @default.
• W2912691364 cites W1970365319 @default.
• W2912691364 cites W1971208896 @default.
• W2912691364 cites W1973667304 @default.
• W2912691364 cites W1975918912 @default.
• W2912691364 cites W1979811833 @default.
• W2912691364 cites W2007872832 @default.
• W2912691364 cites W2009423208 @default.
• W2912691364 cites W2032166347 @default.
• W2912691364 cites W2063377212 @default.
• W2912691364 cites W2100928937 @default.
• W2912691364 cites W2118503880 @default.
• W2912691364 cites W2155101465 @default.
• W2912691364 cites W2160107406 @default.
• W2912691364 cites W2164599562 @default.
• W2912691364 cites W2179464188 @default.
• W2912691364 cites W2199618292 @default.
• W2912691364 cites W2222086386 @default.
• W2912691364 cites W2289712604 @default.
• W2912691364 cites W2293077587 @default.
• W2912691364 cites W2403787004 @default.
• W2912691364 cites W2462649057 @default.
• W2912691364 cites W2486507255 @default.
• W2912691364 cites W2521503673 @default.
• W2912691364 cites W2527129822 @default.
• W2912691364 cites W2530419161 @default.
• W2912691364 cites W2559804019 @default.
• W2912691364 cites W2560296800 @default.
• W2912691364 cites W2566129761 @default.
• W2912691364 cites W2588916311 @default.
• W2912691364 cites W2603526557 @default.
• W2912691364 cites W2618641368 @default.
• W2912691364 cites W2620473448 @default.
• W2912691364 cites W2749935541 @default.
• W2912691364 cites W2756219586 @default.
• W2912691364 cites W2765537501 @default.
• W2912691364 cites W2767847180 @default.
• W2912691364 cites W2789830121 @default.
• W2912691364 cites W2791504329 @default.
• W2912691364 cites W2792937256 @default.
• W2912691364 cites W2797401631 @default.
• W2912691364 cites W2798160602 @default.
• W2912691364 cites W2801460366 @default.
• W2912691364 cites W2802899563 @default.
• W2912691364 cites W2804202174 @default.
• W2912691364 cites W2804647264 @default.
• W2912691364 cites W2804762794 @default.
• W2912691364 cites W2805060661 @default.
• W2912691364 cites W2806413184 @default.
• W2912691364 cites W2884587213 @default.
• W2912691364 cites W2896175597 @default.
• W2912691364 doi "https://doi.org/10.1016/j.euo.2019.01.002" @default.
• W2912691364 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31277773" @default.
• W2912691364 hasPublicationYear "2019" @default.
• W2912691364 type Work @default.
• W2912691364 sameAs 2912691364 @default.
• W2912691364 citedByCount "20" @default.
• W2912691364 countsByYear W29126913642019 @default.
• W2912691364 countsByYear W29126913642020 @default.
• W2912691364 countsByYear W29126913642021 @default.
• W2912691364 countsByYear W29126913642022 @default.
• W2912691364 crossrefType "journal-article" @default.
• W2912691364 hasAuthorship W2912691364A5027991868 @default.
• W2912691364 hasAuthorship W2912691364A5032422193 @default.
• W2912691364 hasAuthorship W2912691364A5034005227 @default.
• W2912691364 hasAuthorship W2912691364A5069476166 @default.
• W2912691364 hasAuthorship W2912691364A5074336646 @default.
• W2912691364 hasConcept C121608353 @default.
• W2912691364 hasConcept C126322002 @default.
• W2912691364 hasConcept C133507102 @default.
• W2912691364 hasConcept C143998085 @default.
• W2912691364 hasConcept C2775910329 @default.
• W2912691364 hasConcept C2775949291 @default.
• W2912691364 hasConcept C2777381376 @default.
• W2912691364 hasConcept C2777472916 @default.
• W2912691364 hasConcept C2777701055 @default.
• W2912691364 hasConcept C2777742743 @default.
• W2912691364 hasConcept C2780057760 @default.
• W2912691364 hasConcept C2780352672 @default.
• W2912691364 hasConcept C509974204 @default.
• W2912691364 hasConcept C535046627 @default.
• W2912691364 hasConcept C71924100 @default.
• W2912691364 hasConceptScore W2912691364C121608353 @default.
• W2912691364 hasConceptScore W2912691364C126322002 @default.
• W2912691364 hasConceptScore W2912691364C133507102 @default.
• W2912691364 hasConceptScore W2912691364C143998085 @default.
• W2912691364 hasConceptScore W2912691364C2775910329 @default.
• W2912691364 hasConceptScore W2912691364C2775949291 @default.

• next